BOUNDLESS BIO INC
BOLDNASDAQ🏆 #3939 by market capEarnings Nov 5US Equity
$2.85▲ $0.10 (+3.45%)
Live1h▲ 0.7%
24h▲ 3.5%
7d▲ 1.6%
14d▲ 15.7%
30d▲ 16.4%
1y▲ 151.8%
🏦Market Cap
$64M
Small Cap
📈Revenue Growth (YoY)
+0.0%
Slowing
📊Gross Margin
0.0%
Thin
💵FCF Margin
0.0%
Thin
⚖️P/S Ratio
0.0x
Cheap
Otter Score
51
Weak
📊
Analyst Ratings
Price
$2.85
Total
20
Raised
3
Lowered
11
| Institution | Action | Rating | Date |
|---|---|---|---|
HC Wainwright & Co. | Reiterated | Buy | 2025-08-11 |
Leerink Partners | Downgraded | Outperform → Market Perform | 2025-05-28 |
Guggenheim | Downgraded | Buy → Neutral | 2024-12-13 |
Evercore ISI Group | Downgraded | Outperform → In Line | 2019-12-08 |
JP Morgan | Downgraded | Overweight → Neutral | 2019-12-05 |
SVB Leerink | Downgraded | Outperform → Perform | 2019-12-04 |
Chardan Capital | Downgraded | Buy → Neutral | 2019-12-03 |
Raymond James | Downgraded | Outperform → Perform | 2019-12-03 |
BMO Capital | Downgraded | Outperform → Perform | 2019-12-03 |
Citigroup | Upgraded | Sell → Neutral | 2019-12-02 |
Wedbush | Downgraded | Outperform → Neutral | 2019-12-02 |
Piper Jaffray | Downgraded | Overweight → Neutral | 2019-12-02 |
Baird | Upgraded | Underperform → Neutral | 2019-12-02 |
William Blair | Downgraded | Outperform → Perform | 2018-11-07 |
B. Riley FBR | Reiterated | Sell | 2018-09-07 |
Mizuho | Upgraded | Neutral → Buy | 2018-08-07 |
H.C. Wainwright | Reiterated | Buy | 2017-12-20 |
Bank of America | Reiterated | Buy | 2017-09-21 |
Cowen & Co. | Reiterated | Outperform | 2016-08-15 |
PiperJaffray | Reiterated | Overweight | 2016-08-15 |
One row per institution, most recent rating